Jan 27 (Reuters) - The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead Sciences' HIV drug Biktarvy and Pfizer's arthritis ...
Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognized useful secondary effect of lowering blood pressure and potentially reduces the risk of heart disease in ...
Researchers have discovered that the GLP-1 hormone targeted by drugs like Wegovy is present in very low amounts inside the ...
The federal government announced the next 15 medicines for which it will seek price reductions with the help of Medicare’s new negotiating power, including the breast cancer drugs Kisqali and Verzenio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results